To explore the involvement of cytokines in ICL pathogenesis, we tested the capacity of ICL patient cells to respond to IL-7 and IL-2, two key γc family cytokines known to control the CD4+ T cell pool size [33]. The gene discussed is IL2; the disease is idiopathic CD4 lymphocytopenia.